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Abstract
Background: The ability of optical coherence tomography (OCT) to visualise macrophages in vivo in 
coronary arteries is still controversial. We hypothesise that imaging of macrophages in OCT could be 
enhanced by means of superparamagnetic nanoparticles.
Methods: We compared the optical backscattering and attenuation of cell pellets containing RAW 
264.7 macrophages with those of macrophagic cell pellets labelled with very small superparamagnetic 
oxydised nanoparticles (VSOP) by means of light intensity analysis in OCT. The labelled macrophages 
were incubated with VSOP at a concentration of 1 mM Fe, corresponding to intracellular iron concen-
trations of 8.8 pg/cell. To study the effect of intracellular accumulation on the backscattering, VSOP 
dilutions without cells were also compared. OCT pullbacks of the PCR tubes containing the cell pellets 
were obtained and light intensity analysis was performed on raw OCT images in polar view, after 
normalisation by the backscattering of the PCR tube. The backscattering was estimated by the peak 
normalised intensity, whilst the attenuation was estimated by the number of pixels between the peak and 
the normalised intensity 1 (peak-to-one).
Results: VSOP-loaded macrophages have higher backscattering than the corresponding unlabelled 
macrophages (peak normalised intensity 6.30 vs. 3.15) with also slightly higher attenuation (peak-to-
one 61 vs. 66 pixels). The backscattering of the nanoparticles in suspension was negligible in the light 
intensity analysis.
Conclusions: VSOP increase significantly the optical backscattering of macrophages in the near-
infrared region, with minimal increase in signal attenuation. This finding enables the enhancement 
of macrophages in conventional OCT imaging with an easily implementable methodology. (Cardiol J 
2017; 24, 5: 459–466)
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Introduction
Atherosclerosis is still the first cause of mor-
tality in the world, especially in developed coun-
tries [1–3]. This mortality is mainly driven by the 
most severe clinical manifestations of atheroscle-
rosis, namely stroke and myocardial infarction, 
that have a common pathological substrate in most 
cases: plaque destabilisation [4, 5]. Inflammation 
and particularly macrophages play a relevant role 
in both atherogenesis and plaque destabilisation 
[6–11]. Macrophages and foam cells are directly 
involved in the progression of the plaque and its 
necrotic core [8, 11]. Furthermore, macrophages 
can release matrix metalloproteinases with proteo-
lytic activity, which digest the extracellular matrix 
and weaken the fibrous components of the cap, thus 
predisposing it to rupture [7, 10, 12–15]. Nonethe-
less the clinical evidence about the involvement 
of macrophages in plaque progression and plaque 
stability is still indirect at a large extent: most 
studies are based in animal models [14], necropsies 
[6, 12, 13] or rare human specimens harvested 
during directional atherectomy (an interventional 
technique not performed in coronary vessels any 
more) [7, 10] or heart transplantation [15]. There 
are scant direct in vivo morphologic studies of mac-
rophages in coronary atherosclerosis in a clinical 
setting that enable the sequential exploration of 
a process dynamic in nature.
Optical coherence tomography (OCT) has 
revolutionised intravascular imaging due to its high 
resolution and its high signal-to-noise ratio, that 
enables very fast and very accurate acquisition of 
a sizeable amount of information [16]. The use of in 
vivo OCT in clinical settings has provided unique 
insights into the pathogenesis of coronary athero-
sclerotic plaques [16], including the detection of 
inflammatory cells like macrophages [17]. The size 
of macrophages (around 20–50 µm in diameter) is 
above the axial resolution of OCT (14 µm) and their 
large nuclei backscatter the near-infrared (NIR) ra-
diation significantly, therefore intimal accumulation 
of macrophages can result in a typical OCT image 
pattern. Nonetheless the sensitivity and specificity 
of unaided conventional OCT for the detection of 
macrophages are still quite controversial, so OCT 
has been granted only with a medium level of evi-
dence for this specific aim in the last consensus 
about OCT image interpretation [18].
Several superparamagnetic iron oxide na-
noparticles used as contrast agents for magnetic 
resonance imaging (MRI) have shown accumula-
tion in macrophages of atherosclerotic plaques 
[19–23], among them very small iron oxide par-
ticles (VSOP) that accumulate as agglomerates 
in phagolysosomes [21]. VSOP are rich in iron, 
which increases significantly the backscattering 
and attenuation of NIR radiation. Moreover, accord-
ing to Rayleigh’s theory, when the particle size is 
substantially lower than the light wavelength, the 
light scattering intensity is proportional to the 
6th power of the particle size and aggregation can be 
monitored by light scattering intensity [24]. Since 
the NIR radiation used for OCT has a wavelength 
between 700 and 1000 nm and the VSOP are below 
20 nm diameter, we hypothesise that the accu-
mulation and formation of aggregates of VSOP in 
macrophages might increase the backscattering and 
attenuation of NIR radiation and therefore enhance 
their visualisation in OCT imaging. 
Methods
We compared the optical backscattering and at-
tenuation of cultured control macrophages with those 
of macrophages loaded with citrate-coated very small 
superparamagnetic iron oxide particles (VSOP). An 
additional sample with VSOP in suspension, without 
cellular culture, was used also as control.
Very small superparamagnetic iron oxide par-
ticles are electrostatically-stabilised citrate-coated 
very-small iron oxide particles. Although they are 
being currently clinically tested as contrast agent 
for visualisation of atherosclerotic plaques in MRI 
[22, 23], they are not approved yet for clinical use. 
Nonetheless VSOP might have interesting phar-
macokinetic advantages, because they cumulate 
directly in phagolysosomal structures of endothe-
lial cells and macrophages, thus enabling imaging 
of inflammation in atherosclerotic plaques within 
3 h after intravenous administration [20, 25]. VSOP 
were synthesised following the well-known co-
precipitation method [26]. Briefly, 7 g of FeCl2 and 
12.35 g of FeCl3.6H2O were separately solubilised in 
50 mL of distilled water and then mixed together at 
2oC. Subsequently, 45 mL of 28 % NH3 were poured 
into the reaction flask and the solution immediately 
turned black due to the formation of VSOP. After 
this, the reaction was kept 1 h more at 2oC under 
mechanical agitation. Once the synthesis of VSOP 
was completed, their surface was modified with so-
dium citrate molecules. In order to do this, 150 mL 
of a 0.1 M sodium citrate trihydrate solution were 
added to the as-synthesised nanoparticles and the 
solution was agitated for 1 h at 80oC. After this, the 
product was isolated with the help of a permanent 
magnet and washed with distilled water. This puri-
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fication step was repeated 3 times and the particles 
were finally re-dispersed in PBS buffer (pH: 7.4).
Sample preparation
Cells from the macrophage cell line RAW 
264.7, derived from mice peritoneal macrophages 
transformed by the AMLV (Abelson Murine Leu-
kemia Virus), were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM), complemented with 
10% of fetal bovine serum (FBS, Gibco), 1% 
penicillin-streptomycin (penicillin 10,000 units/mL, 
streptomycin 10 mg/mL; Sigma-Aldrich) and in-
cubated at 37°C in a 5% carbon dioxide humidified 
atmosphere. Cells were regularly passaged until 
reaching more than 80% confluence and medium 
was exchanged every 2 days.
Nanoparticles uptake was performed with 
macrophages seeded at 100,000 cells/cm2 in 
75 cm2 tissue culture flasks to allow overnight 
adherent cell recovery and proliferation. Follow-
ing day, growth medium was removed and culture 
flasks were washed twice with phosphate buffered 
saline (PBS) followed by addition of NP solution 
in DMEM without phenol red and complemented 
with 1% FBS. Cells were incubated with VSOP 
(1 mM Fe final concentration) for 24 h at 37°C in 
a 5% carbon dioxide humidified atmosphere. Non-
bound nanoparticles were removed by washing 
3 times with PBS, centrifugation (1,000 rpm for 
5 min) and cell passage into a 25 cm2 at 100,000 
cells/cm2. Overnight cell recovery was allowed un-
der cell growth conditions before cell pellet collec-
tion. Five different test samples were precipitated 
in 0.2 mL transparent polypropylene thin-walled 
PCR tubes (Applied Biosystems) to study their op-
tical properties. These samples consisted of 2 cell 
pellets for RAW 264.7, containing 4 × 106 cells in 
a volume of 10 µL: 1) Cell pellet with non-labelled 
macrophages, used as control; 2) Macrophages 
incubated with VSOP 1 mM Fe. In order to study 
the effect of cellular accumulation of the nanoparti-
cles on the optical backscattering and attenuation, 
an additional control sample containing VSOP in 
suspension without cells was arranged: 3) VSOP 
1 mM Fe in suspension (300 µL).
OCT acquisition
A Dragonfly optical catheter (Saint Jude Medi-
cal, St. Paul, Minnesota, USA) was fixed on the 
surface of a grid and the PCR tubes containing 
the test samples were set pairwise at both sides 
of the optical catheter, aligning the walls of their 
tapered tip in parallel with the catheter, so the test 
samples could be imaged through the part of the 
tube where the wall was thinnest. A pullback was 
then acquired at open air with an Ilumien-Optis 
Fourier-domain OCT system (Saint Jude Medical, 
St. Paul, Minnesota, USA) at a rotation speed of 
180 Hz and a pullback speed of 20 mm/s (Fig. 1).
The following pairs were selected for the OCT 
acquisition, in order to enable a direct comparison 
of their optical properties: 1) Non-labelled mac-
Figure 1. Optical coherence tomography (OCT) imaging of the test samples. Example of an OCT cross-section selected 
for the intensity analysis, as seen in the OCT console (A) and corresponding to the log-transformed image of the raw 
OCT signal in Cartesian view, as seen in the interface of the quantification software (B). The cross-section shows 
a pair of reaction tubes containing cell pellets of RAW 264.7 non-labelled macrophages (*) and very small superpara-
magnetic oxydised nanoparticles-loaded macrophages (arrow), displayed over a grid ().
A B
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rophages vs. macrophages labelled with VSOP, 
2) Macrophages labelled with VSOP vs. VSOP in 
suspension.
Light intensity analysis
A representative cross-section was selected 
for each pair of tubes, in which both test samples 
were visible at the highest quality. Using the polar 
view of the log-transformed OCT signal, quantifica-
tion frames of exactly 400 × 50 pixels were placed 
in each test sample at the closest point to the opti-
cal catheter, starting at and including the interface 
with the PCR tube and extending into the depth 
of the study sample up to the complete attenua-
tion of the optical signal (Fig. 2), thus ensuring 
a perfect alignment of the measurements with the 
irradiation of the NIR beam. The coordinates of 
each quantification frame were registered.
The OCT images of the selected cross-sections 
were then displayed as raw linear signal in the polar 
view, and quantification frames of 400 × 50 pixels 
were then placed at exactly the same coordinates 
previously registered under guidance of the log-
transformed signal. The average light intensity 
values of the 50 transversal pixels were then longi-
tudinally recorded along the 400 pixels. The absolute 
intensity values were then normalised using the 
intensity of the backscattering at the corresponding 
PCR tube: 50 × 20 mm control frames were placed 
immediately proximal to the each sample quantifica-
tion frame, with neither solution of continuity nor 
overlap (Fig. 2); the absolute light intensity values 
were then divided by the average intensity meas-
ured in the 50 × 20 control frame at the PCR tube. 
This way, the normalised intensity values express 
the light intensity as the n-fold value with respect 
to the intensity of the corresponding PCR tube: 
a normalised intensity of 1 is equivalent to the same 
light intensity as the PCR tube, normalised values 
between 0 and 1 correspond to intensity values 
lower than the intensity of the tube, whilst values 
> 1 correspond to intensity values above the in-
tensity of the tube. The backscattering is estimated 
as the peak intensity value of the sample, whereas 
the attenuation is estimated as the number of pixels 
between the peak intensity value and the normalised 
intensity of 1 (peak-to-one).
Results
Light intensity analysis with OCT
Very small superparamagnetic iron oxide 
particles-loaded macrophages show enhanced 
backscattering in conventional log-transformed 
OCT imaging, i.e. they appear brighter than unla-
belled macrophages, so as to be noticeable by the 
unaided eye (Fig. 3). This qualitative observation 
is substantiated by light intensity analysis of the 
linear raw OCT signal: VSOP-loaded macrophages 
have higher backscattering than the corresponding 
unlabelled macrophages (peak normalised intensity 
6.30 vs. 3.15) with also slightly higher attenuation 
of the signal (peak-to-one 61 vs. 66 pixels) (Table 1, 
Fig. 4). VSOP in suspension do not have any signifi-
cant backscattering (it is lower than the PCR tube 
containing the test sample: peak normalised intensity 
0.94) (Table 1, Fig. 4) in the light intensity analysis.
Discussion
The main findings of this study can be sum-
marised as follows: 1) VSOP-loaded macrophages 
show more intense optical backscattering than 
ordinary unlabelled macrophages in the NIR wave-
lengths used in OCT. 2) Imaging of macrophages in 
OCT can be enhanced by superparamagnetic iron 
oxide nanoparticles, resulting in twice as much 
backscattering as the unlabelled macrophages, 
but only a slight increase in the signal attenuation.
These results confirm the driving hypothesis 
of this study and encourage the further develop-
ment of nanoparticles-based methods for visu-
alisation of macrophages and inflammatory cells 
in the coronary vessels by means of OCT. Since 
the backscattering of a structure determines how 
bright we will see that structure in OCT, whilst 
its attenuation determines whether we will see 
shadowing behind that structure or not, a tech-
nique which doubles the backscattering with only 
a minimal increase in the attenuation is expected 
to render a more-than-twice brighter image (de-
pending on the log-transformation) with somewhat 
more shadowing. Figure 3 presents a paradigmatic 
example.
Interestingly this backscattering enhance-
ment depends strictly on the cellular accumulation 
of the VSOP within the macrophages. A similar 
concentration of VSOP in suspension, without 
cells, results in no significant backscattering at all 
in the light intensity analysis with OCT (Table 1, 
Fig. 1). The uptake and accumulation of VSOP in 
phagolysosomal structures of the cytosol of the 
macrophage might increase the local concentra-
tion of the nanoparticles as to form large VSOP 
aggregates that are effective scatterers [21], since 
the scattering increases with the 6th power of the 
particle size according to Rayleigh’s theory [24]. 
The fact that this macrophagic enhancement comes 
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only at the cost of a minimal increase in the at-
tenuation of the signal is also important for OCT 
imaging, because an excess of shadowing could 
preclude the appropriate imaging of other compo-
nents of the plaque, thus limiting the usefulness of 
this technique. Nonetheless we must keep in mind 
that the accumulation of unlabelled macrophages 
attenuates itself the signal remarkably, so the true 
impact of this additional increase in attenuation 
needs to be defined after in vivo studies.
Figure 2. Light intensity analysis of the selected optical coherence tomography cross-sections. Polar view of the 
cross-section showed in Figure 2. The log-transformed image (A) is used to place the quantification frames (400 × 50) 
for the sample of non-labelled macrophages (*) and for the sample of very small superparamagnetic iron oxide 
particles-loaded macrophages (arrow) at the point in which each test tube is closest to the optical catheter. The frames 
are aligned with the optical beam and start at the interface tube-sample up to the depth of the sample, where the 
optical signal is completely attenuated. The coordinates of the quantification frames were registered and replicated 
in the linear raw signal (B) for the intensity analysis. The intensity of a small 20 × 50 area at the proximal tip of each 
quantification frame (red arrows), corresponding to the backscattering of the PCR tube, was measured and used to 
normalise the absolute intensity values.
A
B
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Table 1. Light intensity analysis of the linear raw optical coherence tomography signal. Backscatter-
ing is estimated as the peak normalised intensity value of the sample. Attenuation is estimated as the 
number of pixels between the peak intensity and the first normalised intensity value below 1. 
Backscattering
(peak intensity)
Attenuation
(peak-to-1)
Pair 1 Macrophages (non-labelled) 3.15 66
VSOP-labelled macrophages 6.30 61
Pair 2 Macrophages (non-labelled) 3.22 73
VSOP suspension (no cells) 0.94 NA
VSOP — macrophages loaded with very small superparamagnetic iron oxide particles; VSOP suspension — very small superparamagnetic 
iron oxide particles in suspension, without cells
Figure 4. A, B. Light intensity analysis of the linear raw optical coherence tomography (OCT) signal. The light in-
tensity was measured in quantification frames of 400 × 50 pixels. The y-axis shows the average intensity in the 
9 transversal pixels, displayed along the 400 longitudinal pixels (x-axis), from the interface with the PCR tube (pixel 1) 
to the furthest part of the test sample from the optical catheter (pixel 400); VSOP — very small superparamagnetic 
iron oxide particles.
A B
Figure 3. Optical coherence tomography (OCT) imaging of very small superparamagnetic iron oxide particles 
(VSOP)-loaded and unlabelled macrophages. Cell pellets containing unlabelled RAW 264.7 macrophage cells (*) and 
macrophage cells loaded with VSOP (arrow), as seen in conventional OCT: Cartesian view (A) and polar view (B). 
VSOP-loaded macrophages show enhanced backscattering, i.e. they appear brighter than the control unlabelled 
macrophages, so as to be noticeable with the unaided eye.
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A technique for macrophagic enhancement 
in conventional OCT might open new perspec-
tives for in vivo imaging of the atherosclerotic 
plaque and contribute to understanding the role 
of inflammation in plaque progress and stability. 
The possibility of sequential assessment of these 
dynamic processes is particularly appealing and 
likely to offer new insights on an old disease. It 
is important to highlight that accumulation of 
macrophages can be already seen in conventional 
intracoronary OCT without need of any enhancer 
[17], even represented in 3-dimensional rendering 
of the vessel [27], however the degree of consensus 
among different investigators regarding the reli-
ability of OCT for the detection of macrophages is 
still low [18]. The use of superparamagnetic iron 
oxide nanoparticles for macrophagic enhancement 
might improve the sensitivity and specificity of 
OCT for the detection of these cells and eventu-
ally contribute to improve the level of consensus 
among the experts. Moreover, the detection of 
macrophages can be certainly of interest for other 
coronary processes with a strong inflammatory 
component, like spontaneous coronary artery dis-
section [28], cardiac allograft vasculopathy [29] or 
in-stent restenosis [30]. 
The implementation of nanoparticles as mac-
rophagic enhancers would be feasible and simple: 
it only requires a previous intravenous injection 
of the nanoparticle. VSOP might have interesting 
pharmacokinetic characteristics as compared with 
other nanoparticles. VSOP are directly taken up 
by endothelial cells and macrophages, cumulate 
in phagolysosomes and reach sufficient levels 
for imaging in less than 3 h after administration 
[20, 21]. The attractive pharmacokinetic profile 
of VSOP must be however balanced with the lack 
of approval for human use yet, although they are 
currently being tested for imaging in magnetic 
resonance [22, 23].
Limitations of the study
The possibility of an irregular distribution 
of the cells or the particles in the pellets cannot 
be completely ruled out. This phenomenon could 
partially explain some of the differences in back-
scattering and attenuation observed between the 
same elements imaged in different pairs. However 
the results are consistent enough as to support the 
driving hypothesis and the differences between 
pairs are most likely due to the many possible fac-
tors determining the absolute backscattering of 
a structure besides its intrinsic optical properties 
(distance to the catheter, beam incidence, etc.). 
Indeed the need to control all these factors led 
to the design of the study as paired comparisons 
of the samples that were simultaneously imaged.
This is a cellular ex vivo study proving the 
usefulness of nanoparticles for macrophagic en-
hancement with conventional OCT. The real po-
tential and limitations of this method must be 
defined in detail by means of in vivo animal and 
ultimately clinical studies. The possibility of non-
selective imaging can limit the applications of this 
new technique, particularly in the case of VSOP, 
which also cumulate in endothelial cells [31] and 
might interfere with the overall quality of the OCT 
acquisition at some extent.
Conclusions
Very small iron oxide particles increase 
significantly the optical backscattering of mac-
rophages in the NIR regions of the spectrum, 
with only a minimal increase in the signal at-
tenuation. This finding enables the enhancement 
of macrophages in conventional OCT imaging with 
a feasible and easily implementable methodology.
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